BDNF/TrkB signaling is activated in several cancers, including breast [17], colon [18], lung [19], pancreatic [20], and ovarian cancers [21], cutaneous melanoma [22], and oral squamous cell carcinoma (OSCC). Here, NTRK2 is linked to cancer.